David Zervos, Jefferies, joins 'Closing Bell Overtime' to talk what he expects from the Federal Reserve and markets in the ...

Navin Fluorine's shares rose over 6% to a new 52-week high after Jefferies maintained a buy rating and set a target of ₹5,280 ...

Jefferies sees up to 29% upside in Ambuja Cement, Navin Fluorine, and Voltas; read the detailed analysis on top picks now!

Jefferies has shared "buy" call on Navin Fluorine and a target price of Rs 5,280, citing long-term monetization of Rs 2,000 ...

Find insight on Hinge Health, Sarepta Therapeutics and more in the latest Market Talks covering Health Care.

Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds ...

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including ...

Jefferies' optimism on Navin Fluorine comes just a day after Morgan Stanley had upgraded the stock to "Equalweight" from its ...

Keep reading for seven secrets from behind-the-scenes… Unlike other reality competition shows, "majority doesn't rule" on The ...

North, a Naperville resident and detective with the Downers Grove Police Department, is a contestant on “The Snake,” a new ...

TransMedics Group Inc. (NASDAQ: TMDX) is one of the 10 best growth stocks to buy according to billionaires. The stock has had ...

The Trump administration has cut US government spending on health research to a 10-year low, forcing universities to dip into ...